Kenneth L Horton has sold SENS and made no open-market buys since Feb 2022

Kenneth L. Horton is a corporate attorney and executive who serves as General Counsel and Corporate Development Advisor at Senseonics Holdings, Inc., a medical technology company focused on implantable continuous glucose monitoring systems.( He has held this role since 2017 (sometimes reported as October 2017), advising the company on legal, strategic, and transactional matters and serving as a named corporate insider in SEC filings and Form 4 trading reports.( As an insider, Horton has been granted equity awards and has conducted multiple trades in Senseonics stock, reflecting his ongoing participation in the company’s long‑term incentive and ownership programs.(

Before joining Senseonics, Horton built a senior‑level career across the life sciences and health technology sectors. He previously served as Chief Legal Officer and Executive Vice President at Vertex Pharmaceuticals from 2012 to 2015, Executive Vice President, Corporate Development and General Counsel at Nordion (Canada) Inc. from 2005 to 2012, and held legal and corporate development leadership roles at Revvity, Inc. (formerly PerkinElmer) and as Chairman of Lumira Capital (USA) Corp.( Horton holds an undergraduate degree from Dartmouth College and a law degree from Harvard Law School, providing the academic foundation for his executive and legal work in highly regulated health technology and biopharmaceutical industries.(

Written by Perplexity from public sources.